These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Deals landscape: notable deals in the pharmaceutical industry in the first quarter of 2008. Shumoogam J; Al-Shamahi A IDrugs; 2008 May; 11(5):351-5. PubMed ID: 18465677 [TBL] [Abstract][Full Text] [Related]
4. The genetics of a pharma merger. Sanseau P; Chabot-Fletcher M; Browne MJ Drug Discov Today; 2009 Apr; 14(7-8):334-6. PubMed ID: 19121408 [TBL] [Abstract][Full Text] [Related]
5. Two decades of commitment to malaria vaccine development: GlaxoSmithKline Biologicals. Ballou WR; Cahill CP Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):289-95. PubMed ID: 18165505 [TBL] [Abstract][Full Text] [Related]
6. Brazil and India access pharma vaccine know-how. Neto RB; Jayaraman K Nat Biotechnol; 2009 Dec; 27(12):1063-4. PubMed ID: 20010560 [No Abstract] [Full Text] [Related]
7. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness]. Hedner T; Gatenbeck L Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257 [No Abstract] [Full Text] [Related]
8. A place in the sun. Abbott A Nature; 2007 Mar; 446(7132):124-5. PubMed ID: 17344823 [No Abstract] [Full Text] [Related]
9. Vaccines as a global imperative--a business perspective. Stéphenne J Health Aff (Millwood); 2011 Jun; 30(6):1042-8. PubMed ID: 21653955 [TBL] [Abstract][Full Text] [Related]
10. The gold industry standard for risk and cost of drug and vaccine development revisited. Pronker ES; Weenen TC; Commandeur HR; Osterhaus AD; Claassen HJ Vaccine; 2011 Aug; 29(35):5846-9. PubMed ID: 21722688 [TBL] [Abstract][Full Text] [Related]
12. Aligning pharmaceutical innovation with medical need. Nathan C Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145 [No Abstract] [Full Text] [Related]
13. BARDA funds vaccine makers aiming to phase out eggs. Strauss S Nat Biotechnol; 2010 Dec; 28(12):1227-8. PubMed ID: 21139593 [No Abstract] [Full Text] [Related]
14. Canada/US: Competition Bureau will not investigate GSK efforts to stop cross-border sales by internet pharmacies. Elliott R Can HIV AIDS Policy Law Rev; 2003 Apr; 8(1):42-4. PubMed ID: 12924309 [TBL] [Abstract][Full Text] [Related]
15. How should we support pharmaceutical innovation? Grootendorst P Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991 [TBL] [Abstract][Full Text] [Related]
16. Bringing business risk into sharp focus. Gruber B; Walsh E Nat Biotechnol; 2012 Jan; 30(1):30-2. PubMed ID: 22231088 [No Abstract] [Full Text] [Related]
17. Biotechnology company's shares dive 67% after drug failure. Dobson R BMJ; 2000 Oct; 321(7268):1039. PubMed ID: 11053161 [No Abstract] [Full Text] [Related]
18. The dominance of Big Pharma: unhealthy relationships? Badcott D; Sahm S Med Health Care Philos; 2013 May; 16(2):245-7. PubMed ID: 22351151 [No Abstract] [Full Text] [Related]
19. Portfolio analysis and R&D decision making. Evans R; Hinds S; Hammock D Nat Rev Drug Discov; 2009 Mar; 8(3):189-90. PubMed ID: 19182818 [No Abstract] [Full Text] [Related]